One-Stop Solution for Library Design, Protein Engineering, Screening and Expression

Unlock the potential of protein discovery and target identification with the combined power of Allozymes' microfluidics platform and GenScript's gene synthesis expertise. This webinar delves into the exciting partnership between these two innovators, showcasing how their collaboration is accelerating research and development pipelines for companies worldwide.

During the webinar, we will cover the following topics:

Explore the innovative microfluidics technology developed by Allozymes for rapid and efficient enzyme discovery and engineering.

Gain insights into GenScript's extensive protein and target identification services.

Discover how the partnership between Allozymes and GenScript streamlines and accelerates the protein discovery process.

Learn how this collaboration empowers researchers to unlock new possibilities in various fields, including drug discovery, biocatalysis, and synthetic biology.

In this webinar, you will learn

Webinar Details

  • Date: 27th March, 2024
  • Time: 3PM SGT
  • Speaker:
Dr. Akbar Vahidi Dr. Akbar Vahidi

CTO, Co-founder, Allozymes

Akbar Vahidi, a scientist-entrepreneur, earned his PhD in Biocatalysis from the National University of Singapore (NUS). During his PhD, he developed biocatalytic systems for APIs and biofuels. His postdoctoral research focused on microfluidics-based enzyme engineering, successfully demonstrating a droplet microfluidics system for near-application screening. He then co-founded Allozymes to commercialize the microfluidics platform developed during his postdoctoral research. Currently, Akbar serves as co-founder and chief technology officer at Allozymes, where he builds future-oriented solutions to accelerate enzyme engineering for diverse cell-free or cell-based applications in synthetic biology, chemicals, and cosmeceuticals.

Dr. Charlie Zou Dr. Charlie Zou

Head of Project Management Dept.of Molecular Biology, GenScript

Dr. Charlie Zou earned his PhD in Microbiology and Immunology from the University of Saskatchewan, Canada. His research focused on the cell division interactome ofNeisseria gonorrhoeaeand its involvement in antimicrobial resistance. In 2018, he joined GenScript as a principal project manager, where he has been involved in key account project management and global library project evaluation. Presently, he leads the molecular biology project management team at GenScript, providing support to global molecular biology customers.

Speaker-related Webinars


Do you like the current new website?